SCREENING FOR OVARIAN-CANCER - THE PRELIMINARY EXPERIENCE OF A FAMILIAL OVARIAN-CANCER CENTER

被引:55
作者
MUTO, MG
CRAMER, DW
BROWN, DL
WELCH, WR
HARLOW, BL
XU, HJ
BRUCKS, JP
TSAO, SW
BERKOWITZ, RS
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,DIV GYNECOL ONCOL,BOSTON,MA 02115
[2] HARVARD UNIV,BRIGHAM & WOMENS HOSP,CTR OBSTET GYNECOL EPIDEMIOL,BOSTON,MA 02115
[3] HARVARD UNIV,BRIGHAM & WOMENS HOSP,DEPT RADIOL,BOSTON,MA 02115
[4] HARVARD UNIV,BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA 02115
[5] HARVARD UNIV,SCH MED,BOSTON,MA 02115
关键词
D O I
10.1006/gyno.1993.1239
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Women with a family history of ovarian cancer represent a high-risk group for the development of epithelial ovarian cancer. From July 1990 through December 1992, 386 women with a first-degree or multiple second-degree relatives with confirmed ovarian cancer were enrolled in a study to assess the utility of screening with transvaginal sonography, color flow doppler, and CA125. The mean age of the group was 41: 85% were premenopausal and 89/384 (23%) had 2 or more relatives with ovarian cancer. An initial ultrasound examination was abnormal in 89/384 (23%), 89% of whom were premenopausal. A persistent ovarian mass was detected in 15 patients and all were surgically proven to be benign. Mean CA125 levels were significantly higher and more variable in pre- vs postmenopausal women. CA125 was ≥35 U/ml in 42/386 (11%) (36-232 U/ml). All but one of these women were premenopausal and 50% subsequently normalized. Two patients who were surgically explored for a rising CA125 had normal ovaries. An additional 19 patients have undergone prophylactic oophorectomy with no consistent histopathologic abnormality identified. These data demonstrate the difficulty inherent in screening a predominantly premenopausal population and do not clearly establish the efficacy of these modalities in the early detection of ovarian cancer. © 1993 Academic Press, Inc.
引用
收藏
页码:12 / 20
页数:9
相关论文
共 31 条
  • [21] PIVER MS, 1982, OBSTET GYNECOL, V60, P397
  • [22] PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P2751, DOI 10.1002/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO
  • [23] 2-J
  • [24] Pourcelot L, 1974, VELOCIMETRIE ULTRASO, P213
  • [25] RULIN MC, 1987, OBSTET GYNECOL, V70, P578
  • [26] FAMILIAL OVARIAN-CANCER - A POPULATION-BASED CASE-CONTROL STUDY
    SCHILDKRAUT, JM
    THOMPSON, WD
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 128 (03) : 456 - 466
  • [27] SCHWARTZ PE, 1991, YALE J BIOL MED, V64, P573
  • [28] TOBACMAN JK, 1982, LANCET, V2, P795
  • [29] TRIMBLE EL, 1991, OBSTET GYNECOL, V78, P1023
  • [30] VANNAGELL JR, 1991, CANCER, V68, P458, DOI 10.1002/1097-0142(19910801)68:3<458::AID-CNCR2820680303>3.0.CO